MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

    S. Parveen, A. Mandaville (Stillwater, USA)

    Objective: SPEAK OUT!® and LOUD Crowd® programs target the communicative functioning of people with Parkinson disease (PD). The current study includes findings from a year-long…
  • MDS Virtual Congress 2021

    Cognitive impairment in patients with Alzheimer’s disease and Parkinson’s disease

    O. Chyniak (Sumy, Ukraine)

    Objective: To compare the results of a neuropsychological study in patients with Alzheimer's disease and Parkinson's disease. Background: Recently, Parkinson's disease (PD) is increasingly considered…
  • MDS Virtual Congress 2021

    Comparisons Between Parkinson’s Disease Patients and At-Risk Individuals: Can Olfactory Deficits and Cognitive Measures Serve as Preclinical Markers?

    L. Pimer, J. Fisk, M. Khan, R. Mckelvey, H. Robertson, T. Rolheiser, K. Schoffer, K. Good (Halifax, Canada)

    Objective: To examine whether individuals at increased risk of developing Parkinson’s disease (PD) show specific cognitive impairments suggestive of progression towards PD. Background: Olfactory deficits…
  • MDS Virtual Congress 2021

    Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

    S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To determine whether hippocampal subfield volumes in non-demented Parkinson’s Disease (PD) are primarily predicted by cognition or CSF β-amyloid 1–42 (Aβ42) levels. Background: The…
  • MDS Virtual Congress 2021

    Effectiveness of a novel cognitive rehabilitation program based on mindfulness and reminiscence in patients with Parkinson’s Disease and Mild Cognitive Impairment: a pilot study

    M. Reitano, M. Dini, F. Ruggiero, S. Tagini, F. Solca, B. Poletti, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: To evaluate the efficacy of a new integrated rehabilitation program based on Mindfulness and Cognitive Training (MILC-tr) on cognitive functions and mood in patients…
  • MDS Virtual Congress 2021

    Community-Based Multidisciplinary Program for People with Parkinson Disease: A 2-year comparison

    S. Parveen, T. Passmore, B. Brickell, S. Jackson (Stillwater, USA)

    Objective: The current study reports outcomes from a 2 year-long community-based multidisciplinary program for individuals with Parkinson disease (PD) and their families based in Oklahoma…
  • MDS Virtual Congress 2021

    The dual cognitive syndrome in Parkinson’s disease: a resting-state functional connectivity study

    Q. Devignes, C. Bordier, R. Viard, G. Carey, L. Defebvre, A. Leentjens, R. Lopes, K. Dujardin (Lille, France)

    Objective: To assess resting-state functional connectivity modifications characterizing the frontostriatal and posterior cortical cognitive subtypes in Parkinson’s Disease (PD) Background: The dual syndrome hypothesis (Kehagia…
  • MDS Virtual Congress 2021

    Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.

    L. Popil, M. Gavriliuc, A. Andrusca, O. Gavriliuc (Chisinau, Republic of Moldova)

    Objective: Evaluate cognitive performance in Parkinson's disease patients receiving a low dose of trihexyphenidyl (THP). Background: Before L-Dopa's discovery, anticholinergic drugs were among the first…
  • MDS Virtual Congress 2021

    In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study

    MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir (Seville, Spain)

    Objective: To assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in a well-characterized multicentric cohort of Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Parkinson’s Disease, Cognitive Function and Health Literacy: A Problem with Shared Decision Making

    O. Kaczmarek, A. Sethi, P. Tierney, B. Bumstead, M. Buhse, E. Kravis, B. Anand, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: To explore the relationship between health literacy and cognitive impairment in PwPD Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder with cognitive, psychiatric…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley